Agile Therapeutics Inc. buy Maxim Group
Start price
22.09.23
/
50%
€0.21
Target price
22.09.24
-
Performance (%)
-
End price
23.09.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Agile Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by Maxim_Group for this prediction
In the thread Agile Therapeutics Inc. diskutieren
Agile Therapeutics, Inc. (NASDAQ: AGRX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for AGRX provided by MarketBeat
In the thread Trading Agile Therapeutics Inc.
Die von Maxim_Group gewählte maximale Laufzeit wurde überschritten